✦ LIBER ✦

Antiplatelet medication after liver transplantation: Does it affect outcome?

✍ Scribed by Ton Lisman; Robert J. Porte

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 62 KB
Volume: 13
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrence of nonalcoholic fatty liver d

Recurrence of nonalcoholic fatty liver disease after liver transplantation: It is common, but does it affect outcome?

✍ Philip N. Newsome 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Graft weight/recipient weight ratio: How

Graft weight/recipient weight ratio: How well does it predict outcome after partial liver transplants?

✍ Mark J. Hill; Michael Hughes; Tun Jie; Melissa Cohen; John Lake; William D. Payn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Partial graft liver recipients with graft weight/recipient weight (GW/RW) ratios Ͻ 0.8% are thought to have a higher incidence of postoperative complications, including small-for-size syndrome (SFSS). We analyzed a cohort of such recipients and compared those with GW/RW Ͻ 0.8% to those with GW/RW Ն

Greater travel time to a liver transplan

Greater travel time to a liver transplant center does not adversely affect clinical outcomes

✍ Amir A. Firozvi; Christine H. Lee; Paul H. Hayashi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

The effect of patient travel time to a transplant center on outcomes is unknown. We compared outcomes between patients living >3 hours (Group A) vs. 90 days to list, listing, survival while listed, transplantation, and posttransplantation survival. Covariates included Model for End-Stage Liver Disea

Mortality following liver resection in U

Mortality following liver resection in US medicare patients: Does the presence of a liver transplant program affect outcome?

✍ Elijah Dixon; Sebastian Schneeweiss; Janice L. Pasieka; Oliver F. Bathe; Francis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Incidence of prolonged length of stay af

Incidence of prolonged length of stay after orthotopic liver transplantation and its influence on outcomes

✍ Jenny O. Smith; Mitchell L. Shiffman; Martha Behnke; R. Todd Stravitz; Velimir A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 1 views

Orthotopic liver transplantation (OLT) is the only effective treatment for end-stage liver disease. Although most patients do well and are discharged promptly, some require prolonged length of stay (PLOS). The prevalence of PLOS, associated factors, and their impact on survival are not well defined.

Does antimitochondrial antibody status a

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation

✍ W R Kim; J J Poterucha; R A Jorgensen; K P Batts; H A Homburger; E R Dickson; R 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

rum. 1 In the past decade, two treatment modalities have Approximately 5% to 10% of patients with features otherbeen shown to be effective in the treatment for PBC, dewise consistent with primary biliary cirrhosis (PBC) lack antipending on the stage of the disease. For patients with less mitochondri